Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Chinese Patent Office
Federal Trade Commission
Mallinckrodt
Cerilliant
Cantor Fitzgerald
Argus Health
Colorcon
Boehringer Ingelheim

Generated: June 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 089743

« Back to Dashboard

NDA 089743 describes FLUPHENAZINE HYDROCHLORIDE, which is a drug marketed by Ani Pharms Inc, Pharm Assoc, Fresenius Kabi Usa, Lannett Co Inc, Mylan, Sandoz, and Watson Labs, and is included in twelve NDAs. It is available from twelve suppliers. Additional details are available on the FLUPHENAZINE HYDROCHLORIDE profile page.

The generic ingredient in FLUPHENAZINE HYDROCHLORIDE is fluphenazine hydrochloride. There are eighteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the fluphenazine hydrochloride profile page.
Summary for 089743
Tradename:FLUPHENAZINE HYDROCHLORIDE
Applicant:Lannett Co Inc
Ingredient:fluphenazine hydrochloride
Patents:0
Therapeutic Class:Antipsychotics
Formulation / Manufacturing:see details
Pharmacology for NDA: 089743
Ingredient-typePhenothiazines
Suppliers and Packaging for NDA: 089743
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FLUPHENAZINE HYDROCHLORIDE fluphenazine hydrochloride TABLET;ORAL 089743 ANDA Lannett Company, Inc. 0527-1791 N 0527-1791-01
FLUPHENAZINE HYDROCHLORIDE fluphenazine hydrochloride TABLET;ORAL 089743 ANDA Lannett Company, Inc. 0527-1791 N 0527-1791-05

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Aug 25, 1988TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1MG
Approval Date:Aug 25, 1988TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2.5MG
Approval Date:Aug 25, 1988TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Cerilliant
AstraZeneca
Citi
Merck
US Army
Medtronic
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.